Renal function is regulated, in part, by both humoral and neuronal factors. It has been postulated that neuronal factors may be less important than humoral factors in regulating renal function, given the fact that patients receiving kidney transplants, which have a defective renal plexus, maintain relatively normal renal function. However, the renal nervous system has been shown to be important in blood pressure regulation. For example, renal nerve ablation decreases blood pressure in both humans and animals \[[@r16], [@r36], [@r42], [@r44]\], and repression of circadian effects on blood pressure has been observed in renal transplant patients \[[@r13], [@r20]\]. Classical studies have shown that introduction of cholinergic agents into the renal artery causes hypotensive effects in mammals \[[@r9], [@r10], [@r46]\]. Barajas *et al.* found histological evidence of nephritic and vascular innervation in mammals and demonstrated an effect of this innervation on renal functions \[[@r3],[@r4],[@r5],[@r6],[@r7], [@r26]\]. However, the specific cellular targets of renal innervation remain unclear.

Previous reports have demonstrated sympathetic and parasympathetic effects on glomeruli, proximal tubules and collecting ducts \[[@r15], [@r24], [@r25], [@r28], [@r32], [@r35]\], but the specific effects on each cell type remain unknown. Several types of adrenergic receptors (ADRs) have been identified in the kidney. A range of ADR α1 and α2 subtypes is expressed by the renal vasculature and by nephrons. Stimulation of these receptors causes arterial vasoconstriction and tubular reabsorption \[[@r21], [@r31], [@r40]\]. The ADR β subtypes are expressed by renin-secreting granule cells and by the proximal tubules \[[@r15], [@r41]\]. The muscarinic acetylcholine (ACh) receptors (mAChRs) are also expressed in cells within the glomeruli, proximal tubules and collecting duct \[[@r24], [@r25], [@r28], [@r32], [@r35]\] where they activate renal solute transport \[[@r32], [@r35]\]. It has been suggested that other renal cell types may express neurotransmitter receptors, but such expression patterns have yet to be defined.

Principal cells within the renal collecting ducts help to regulate urine concentration. Principal cells are segment-specific cells that are interspersed with intercalated cells (ICCs) in the renal epithelium. One of the major functions of principal cells is to reabsorb water through the arginine-vasopressin (AVP)-sensitive water channel, aquaporin 2 (AQP2) \[[@r27], [@r43]\]. Similarly, ICCs play a role in acid/base regulation by modulating proton conductance. ICCs can be distinguished by the expression of AQP6. AQP6 is a member of the aquaporin family that is localized to intracellular vesicles and is permeable to both water and anions \[[@r27], [@r43]\]. ICCs are classified into three types (A, B and non-A non-B) based on the expressions and intracellular localization of proton pumps and anion exchangers \[[@r19]\]. In the kidney, acid/base equilibrium is primarily regulated by the proximal tubules and collecting ducts \[[@r14]\]. The regulation of acid/base balance in proximal tubular cells can be affected by the cholinergic agent carbachol, suggesting some measure of neuronal influence \[[@r32], [@r35]\]. ICCs co-express AQP6 and the proton pump H^+^-ATPase on intracellular vesicles. These 2 molecules may act together to control acid/base balance within the body \[[@r30], [@r49]\]. Because ICCs are interspersed within the collecting duct epithelium, it has been difficult to determine the specific effect of neuronal input on the ability of these cells to regulate the pH of body fluid.

The M-1 cell line consists of immortalized mouse renal epithelial cells. M-1 cells express H^+^-ATPase and several anion transporters that are expressed by renal ICCs \[[@r37], [@r38]\]. To determine if M-1 cells are a useful model with which to investigate the effects of neurotransmitters on ICCs, we examined M-1 expression of the ADR and mAChR neurotransmitter receptors and the expression and location of these receptors in murine ICCs.

MATERIALS AND METHODS {#s1}
=====================

*Cell culture*: The M-1 mouse kidney epithelial cell line was obtained from DS Pharma Biomedical Co., Ltd. (Osaka, Japan). Cells were incubated in DMEM/Ham's F12 (1:1 mixture, Wako, Osaka, Japan) supplemented with 2 mM L-glutamine, 5% fetal bovine serum (Nichirei Biosciences, Tokyo, Japan) and 5 *µ*M dexamethasone (Sigma-Aldrich, St. Louis, MO, U.S.A.) at 37°C in a humidified atmosphere of 5% CO~2~ and 95% air.

*Animal*s: Adult male C57BL/6J mice (7 weeks old, 20--25 g) were obtained from Crea Japan, Inc. (Tokyo, Japan) and used according to protocols approved by The Animal Care and Use Committee at Hyogo College of Medicine. Mice were kept in separate cages and maintained under a 12-hr light/dark cycle at a constant temperature of 25°C. Food and water were given *ad libitum* until sacrifice.

*Reverse transcription (RT)-PCR*: Cultured cells (10--50 × 10^6^ cells/m*l*) and murine kidneys (0.1 mg/m*l*) were homogenized with Trizol reagent (Invitrogen, Carlsbad, CA, U.S.A.), and total RNA was obtained according to the manufacturer's protocol. Genomic DNA was eliminated by incubating the samples with RNase free DNase I (Takara, Otsu, Japan). cDNA was synthesized with oligo dT and RTase (Toyobo, Osaka, Japan) from 2 *µ*g of total RNA. PCR was performed with ExTaq^TM^ Hot Start version (Takara) with primers specific for the ADR subtypes, the mAChR subtypes, the aquaporins and the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) ([Table 1](#tbl_001){ref-type="table"}Table 1.List of aquaporin and neurotransmitter receptor primersGeneSubtypeGene nameUpper primer 5′- to −3′Lower primer 5′- to −3′Size (bp)Accession No.AquaporinsAQP2*Aqp2*ggggcccacatcaaccctgcagagcattgacagccaggtc172BC019966AQP6*Aqp6*actggctgttccatgaacccaggaagtggccaggaggtac206BC115586.1Adrenaline receptorsα1*Adra1a*aatgcttctgaaggctccaatcccaggatctcaaagatgg252BC113139.1α2*Adra2b*ctggcctcgacctcactaagcacctcaacccacttccagt278BC156761.1β2*Adrb2*aagaataaggcccgagtggtgtcttgagggctttgtgctc383BC032883.1β3*Adrb3*actcctcgtaatgcc acc aggctggggtaagtctgtcagc389BC132000.1Muscarinic acetylcholine receptorsm1*Chrm1*tactggcgcatctaccgggagagaaggtctttctcttggc447BC094242.1m3*Chrm3*cacggcagactctaactggatggggagttcaccaccaagagctggaagcccagt363BC129893.1m4*Chrm4*gatggtgttcattgcgacaggcagaaatagcggtcaaagc307X63473.1m5*Chrm5*caggcctcctggtcatcctccgttagataccaccaatcggaacttataggcaac355BC120615.1Glyceraldehyde-3-phosphate dehydrogenase*Gapdh*tgaaggtcggtgtgaacggatttggccatgtaggccatgaggtccaccac982M32599.1). PCR conditions were as follows: hot start initiation at 94°C for 1 min followed by 35 cycles of 94°C for 30 sec, 60 or 64°C for 30 sec and 72°C for 30 sec, and ending with an additional extension reaction at 72°C for 10 min. In the GAPDH, PCR was performed with 20 cycles. PCR products were electrophoresed in 1.5% agarose gels and visualized with ethidium bromide and UV transillumination (ATTO, Tokyo, Japan). Negative control examination was performed with the same procedure, except for the omitting of RTase. To confirm whether the amplicons are normal in M-1 cell genome, PCR was also carried out with genomic DNA as templates.

*Immunoblot*: Confirmation of the expressions of ICC cellular markers and neurotransmitter receptors was performed by immunoblot. Normal murine kidney tissue and M-1 cells (5 × 10^6^ cells/test) were homogenized, and then, total membrane proteins were purified by Minute^TM^ Plasma Membrane Protein Isolation kit (Invent, Eden Prairie, MN, U.S.A.). The total protein fraction was collected and denatured in 125 mM Tris-HCl (pH 7.6) containing 4% SDS, 1mM EDTA, 0.1 M dithiothreitol, 20% glycerol and 0.005% bromophenol blue at 4°C overnight. Samples were electrically separated in a urea denaturation polyacrylamide gel (10% polyacrylamide, 4 M urea). Separated proteins were transferred to polyvinylidene difluoride membrane at 1.5 mA/cm^2^ for 50 min by semidry blotter (\#EPE103AA, Advantech, Tokyo, Japan). Protein-transferred membranes were washed with phosphate buffered saline containing 0.05% Tween 20 (PBST) and blocked with Block Ace^TM^ (DS Pharma Biomedical) containing 0.5% normal goat serum (Vector, Burlingame, CA, U.S.A.). Membranes were incubated with diluted primary antibodies including rabbit anti-AQP6 polyclonal antibody (pAb, \#AQP-006, Alomone Labs, Jerusalem, Israel), rabbit anti-AQP2 pAb (\#AQP-002, Alomone labs), rabbit anti-ADR b2 pAb (\#Sc-569, Santa Cruz, TX, U.S.A.) and rabbit anti-mAChR m1 pAb (\#010, Alomone Labs) for 2 hr at room temperature or at 4°C overnight. After washing with PBST, membranes were incubated with diluted horseradish peroxidase-conjugated goat anti-rabbit IgG (Millipore, Billerica, MA, U.S.A.) for 2 hr at room temperature. Signal detection was carried out with chemi-luminescence ECL^TM^ prime (GE Healthcare, Little Chalfont, U.K.) and a luminescent image analyzer LAS-4010 (GE Healthcare). Control experiments were performed with primary antibodies pre-incubated with protein-specific blocking peptides.

*Immunofluorescence of M-1 cells*: To characterize the M-1 cells with expression of AQPs, the immunofluorescence was carried out by using anti-AQP2 and AQP6 antibodies. M-1 cells were cultured under the condition mentioned above in the 4-well slide chambers (Thermo Fischer Scientific, Waltham, MA, U.S.A.). Cells were fixed with 4% paraformaldehyde in PB for 10 min at room temperature. After washing with PBST, they were blocked with 10% normal goat serum in PBST, followed by incubation with primary antibodies (AQP2: \#AQP-002; AQP6: \#AQP-006, Alomone Labs) for 1 hr. After washing with PBST, they were incubated with rhodamine-conjugated goat anti-rabbit IgG pAb (Millipore). Light and fluorescent microscopic observations were obtained using a BX-51 (Olympus, Tokyo, Japan), and data were imported from a DP-73 CCD camera (Olympus).

*Immunohistochemistry of the neurotransmitters on the renal tissues*: Animals were anesthetized with medetomidine (0.3 mg/kg), midazolam (4 mg/kg) and butorphanol (5 mg/kg). Anesthetized animals were intracardially perfused with normal saline, followed by Zamboni's fixative. Kidneys were removed, dissected into small sections and then additionally fixed in Zamboni's fixative at 4°C overnight. Specimens were immerged in phosphate buffer (pH 7.4) containing graded sucrose (10--20%) and quickly frozen at −80°C. Tissues were sliced into 7 *µ*m sections by cryostat (Leica, Wetzlar, Germany), transferred to glass slides and air-dried. Before immunostaining, antigen retrieval was performed by submerging sections in 1 mM EDTA in Tris-HCl (pH 8.0) for 5 min at 115°C. Immunohistochemical staining was performed with the avidin-biotin complex (ABC) system. Tissue sections were submerged in 0.3% H~2~O~2~ in methanol for 30 min to eliminate endogenous peroxidases. Sections were then blocked with ABC blocking reagent (Vector) followed by 10% normal goat serum in PBST and incubated with rabbit anti-ADR β2 pAb (\#SC-569) or rabbit anti-mAChR m1 pAb (\#010). After washing with PBST, sections were incubated with biotin-conjugated goat anti-rabbit IgG pAb (Millipore), and the ABC reaction was performed (ABC *Elite*, Vector). The sections were washed with PBST and then incubated in 0.04% diaminobenzidine containing 0.3% nickel ammonium and 0.003% H~2~O~2~ (DAB-Ni, Vector) for 10 min. After visualization under the microscope, sections were washed twice with 0.1 M glycine buffer (pH 2.5) for 5 min. After neutralization with PBST, sections were re-immunostained with the AQP6 antibody for cell-type identification. In brief, specimens were blocked with 10% normal goat serum in PBST and then incubated with rabbit anti-AQP6 pAb (\#AQP-006). After washing with PBST, sections were incubated with rhodamine-conjugated goat anti-rabbit IgG pAb (Millipore). Light and fluorescent microscopic observations were obtained using a BX-51, and data were imported from a DP-73 CCD camera.

*Acetylcholine (AChE) staining*: Histochemistry of AChE in murine kidney slices was performed by the modified Karnovsky-Roots method \[[@r45]\]. Murine renal tissues were sliced into 7 *µ*m sections on a cryostat and transferred to glass slides. Specimens were washed in 0.1 M maleate buffer (pH 6.0) and then incubated in reaction buffer containing 36 *µ*M acetyltiocholine iodide, 5 *µ*M hexacyano-ferriciate, 30 *µ*M copper sulfate and 50 *µ*M sodium citrate in 0.1 M maleate buffer (pH 6.0) for 30 min at room temperature. Sections were then washed with 50 mM Tris-HCl (pH 7.6) and incubated with DAB-Ni for 10 min. The control experiment was performed by omitting acetylthiocholine iodide from the reaction buffer. Double-labeling histochemistry was carried out with anti-AQP6 antibodies for cell type identification.

RESULTS {#s2}
=======

To determine whether the M-1 cell line expresses renal ICC markers, RT-PCR was performed on total RNA isolated from M-1 cells and from normal murine kidney. AQP6, which is specifically expressed by ICCs in the mammalian kidney, was amplified from total RNA isolated from M-1 cells. Further, immunoblotting of protein isolated from M-1 cells revealed the typical AQP6 banding pattern \[[@r50]\], consisting of a low molecular weight monomeric band and a high molecular weight glycosylated band ([Fig. 1A](#fig_001){ref-type="fig"}Fig. 1.Characterization of M-1 cellular expression of aquaporin A) Characterization of AQP6 mRNA and protein expression in M-1 cells by RT-PCR (upper column) and immunoblot (middle column), respectively. An AQP6 specific band (arrowhead) was amplified from M-1 cellular total RNA (lane 1), M-1 cellular genomic DNA (gDNA, lane 3) and normal mouse kidney total RNA (MK cDNA, lane 4). No positive band was observed in RTase (−) negative control lane (lane 2). Immunoblot demonstrating the AQP6 specific band (arrowhead) and glycosylated band (double arrowhead) in total membrane protein extracted from M-1 cells (lane 1) and murine kidney (MK, lane 2). B) Characterization of AQP2 mRNA and protein expression in M-1 cells by RT-PCR (upper column) and immunoblot (middle column), respectively. AQP2 mRNA was not amplified from M-1 cellular total RNA (lane 1), although it was observed in M-1 gDNA (lane 3) and MK cDNA (lane 4). Similarly, AQP2 protein was not observed in total membrane protein isolated from M-1 cells (lane 1), although it was observed in total membrane protein isolated from the MK (lane 2). An arrowhead and a double arrow indicate the unglycosylated and glycosylated bands, respectively. Immunofluorescence showed the M-1 cells were positive to the AQP6 antibody (A, lower column), but negative to AQP2 antibody (B, lower column). Bar=50*µ*m.). In contrast, AQP2, which is specifically expressed in collecting duct principal cells, was amplified at high levels in total RNA isolated from murine renal tissue, but at very low levels in total RNA isolated from M-1 cells ([Fig. 1B](#fig_001){ref-type="fig"}). Immunoblotting analysis revealed the typical AQP2 banding pattern \[[@r1]\], consisting of a low molecular weight monomeric band and a high molecular weight glycosylated band, in protein isolated from murine renal cell membranes, but not from M-1 cell membranes ([Fig. 1B](#fig_001){ref-type="fig"}). These banding patterns were not seen in control experiments in which the primary antibodies were either omitted or incubated with blocking peptides. Immunofluorescence of cultured cells showed the AQP6 positive, but the AQP2 negative ([Fig. 1](#fig_001){ref-type="fig"}). These findings indicate that the expression patterns of M-1 cells are more similar to ICCs than to principal cells.

Neurotransmitter receptor expression (α1, α2, β2 and β3 ADRs and m1, m3, m4 and m5 mAChRs) in M-1 cells was examined by RT-PCR. Because ADR β1 and mAChR m2 were not expressed in the mouse kidney (data not shown), they were excluded from this study. The α2 and β2 ADR subtypes were amplified from total RNA isolated from M-1 cells ([Fig. 2A](#fig_002){ref-type="fig"}Fig. 2.Expression of adrenergic receptors in M-1 cells and histological localization of the β2 receptor in the mouse kidney. A) RT-PCR (upper column) of ADRs in M-1 total cellular RNA (cDNA, lane 1) and genomic DNA (gDNA, lane 3). The α2 (second row) and β2 (third row) ADRs were amplified from M-1 total cellular RNA, but the α1 (first row) and β3 (fourth row) ADRs were not. No positive band was observed in RTase (−) negative control lane (lane 2). Immunoblot of the β2 receptor (lower column) shows a specific 60--75 kDa band (arrowhead). B) and C) Immunohistochemistry of the β2 receptor (B) and AQP6 (C) in the mouse renal cortex (arrows indicate the same points on both images). Arrows indicate AQP6-positive, β2-positive cells, and arrowheads indicate AQP6-positive, β2-negative cells in the CCDs. D) and E) Immunohistochemistry of the β2 receptor (D) and AQP6 (E) in the outer medulla. β2 receptor immunoreactivities were observed to the straight segment of proximal tubules, but not in the collecting ducts. Arrowheads (AQP6 positive cells) indicate the same points on both images. G: glomerulus. Bar=20 *µ*m (B and C) and 100 *µ*m (D and E).). When expression levels were normalized to genomic DNA amplification, the β2 subtype was expressed at higher levels than the α2 subtype. Further, expression of the β2 receptor protein was observed in membrane proteins isolated from M-1 cells ([Fig. 2A](#fig_002){ref-type="fig"}). The α2 receptor subtype was not by immunoblot in M-1 cells (data not shown). No expression of the α1 or β3 ADR subtypes was observed in mRNA isolated from M-1 cells.

We observed β2 ADR immunoreactivity in proximal tubules and in cortical collecting ducts (CCDs) within the renal cortex ([Fig. 2B](#fig_002){ref-type="fig"}). We found that, in the CCDs, β2 receptor-positive cells were also positive for AQP6 ([Fig. 2C](#fig_002){ref-type="fig"}). However, several AQP6-positive ICCs did not demonstrate β2 receptor expression. In the renal medulla, neither outer nor inner medullary collecting ducts demonstrated β2 receptor expression ([Fig. 2D and 2E](#fig_002){ref-type="fig"}). These findings suggest that two types of ICCs exist in the CCDs: those that do or do not express the β2 ADR.

Examination of the expression of mAChRs in M-1 cells by RT-PCR revealed that the m1, m4 and m5 mAChRs are expressed by M-1 cells, but the m3 subtype is only expressed at a very low level ([Fig. 3](#fig_003){ref-type="fig"}Fig. 3.Expression of mAChRs in M-1 cells and immunohistochemical localization of the m1 ADR in the mouse kidney. A) RT-PCR (upper column) of m1, m3, m4 and m5 receptor subtypes in M-1 total cellular RNA (lane 1, arrowheads). Genomic DNA was used as a control (lane 3). No positive band was observed in RTase (−) negative control lane (lane 2). Immunoblot (lower column) demonstrating the presence of the m1 receptor subtype in the M-1 total membrane protein fraction. The most intense band is observed at 55 to 70 kDa (arrowhead). B) to E) Immunohistochemistry demonstrating the presence of the m1 mAChR (B and D) and AQP6 (C and E) in the cortex (B and C) and renal outer medulla (D and E). Arrows indicate AQP6-positive, m1-positive cells. Arrowheads indicate AQP6-positive, m1-negative cells. Reactions of m1 antibody were stronger to the medullary collecting ducts (B) than to the CCDs (D). Bar=20 *µ*m.). Immunoblot analysis revealed that the m1 subtype was located in the membrane fraction of M-1 cellular proteins ([Fig. 3A](#fig_003){ref-type="fig"}). Immunoblot analysis did not detect the m4 and m5 subtypes, despite several attempts with multiple antibodies. Immunohistochemical analysis of the m1 subtype revealed localization to the CCDs and to the outer and inner medullary collecting ducts ([Fig. 3D](#fig_003){ref-type="fig"}). The m1 subtype was observed in almost all collecting duct cells, suggesting that it is expressed by both principal cells and ICCs. Reactivity was stronger in medullary cells than in cortical cells ([Fig. 3B](#fig_003){ref-type="fig"}). Secondary staining with the AQP6 antibody, which identifies ICCs, showed that AQP6-positive cells throughout the collecting ducts were also m1-positive ([Fig. 3B to 3E](#fig_003){ref-type="fig"}). However, several m1-negative ICCs were also observed in the collecting ducts. These findings indicate that principal cells and ICCs in the collecting ducts express the m1 receptor and provide further evidence that two types of ICCs may exist, namely, those that do or do not express the m1 mAChR.

Double-labeling histochemistry using the modified Karnovsky-Roots method demonstrated localization of AChE to the glomeruli, the arterioles, the nerve fibers along the interlobular artery and the collecting ducts ([Fig. 4A and 4B](#fig_004){ref-type="fig"}Fig. 4.Dual staining of AChE and AQP6 in CCDs. A) AChE was localized to the glomerulus (G) and the nerve fibers along the interlobular arterioles (arrows) B) AChE in CCD cells was stained with the modified Karnovsky-Roots method (arrows). C) AQP6 in the mouse renal cortex was stained by immunohistochemistry (arrowheads). AChE and AQP6 staining did not overlap in the CCDs. The arrows and arrowheads indicate identical cells in panels A and B. Bar=20 *µ*m.). In the collecting ducts, AChE was observed in the cortex and the outer medulla, but not in the inner medulla. Both AChE-positive and AChE-negative cells were scattered throughout these regions. AChE-positive cells did not stain with the AQP6 antibody ([Fig. 4B and 4C](#fig_004){ref-type="fig"}), suggesting that they may be principal cells.

DISCUSSION {#s3}
==========

In this study, we examined the expression and localization of neurotransmitter receptors in the ICCs of the murine renal collecting ducts and in the murine renal epithelial M-1 cell line. RT-PCR and immunoblot analysis revealed that AQP6, but not AQP2, mRNA and protein are expressed in M-1 cells. As a control, we confirmed that both AQP6 and AQP2 can be amplified from M-1 genomic DNA, indicating that AQP2 is not defragmented in M-1 cellular DNA. These findings suggest that M-1 cells demonstrate ICC-like properties *in vitro*.

We identified both adrenergic and cholinergic receptor expression in M-1 cells. Multiple ADR subtypes have been identified in the kidney \[[@r11]\]. Activation of the ADR α subtype leads to vascular smooth muscle contraction and proximal tubule reabsorption \[[@r8], [@r34]\]. Activation of the ADR α2 subtype decreases cAMP in the distal tubules and collecting ducts, leading to AVP release \[[@r2], [@r31], [@r33]\]. In M-1 cells, the α2 receptor subtype was detected by RT-PCR, but not by immunoblot. It is difficult to determine whether the α2 receptor is activated in M-1 cells and ICCs. In contrast, β2 ADR mRNA and protein were both detected in M-1 cells. In murine renal tissue, β2 receptor immunoreactivity was localized to the proximal tubules and collecting ducts. We observed that β2-positive cells in the collecting ducts were also AQP6-positive, indicating the intercalated cell type. We observed no β2 receptor immunoreactivity in the medullary collecting ducts, indicating that the β2 ADR may only be expressed by the ICCs of CCDs. Noradrenergic nerve fibers generally originate from the sympathetic ganglia, then run along the renal artery and branch with the interlobular artery \[[@r3]\]. The interstitial space between the renal tubules and the renal vasculature is extremely narrow \[[@r19]\], and it has been difficult to determine whether nerve fibers in this space innervate tubular cells or vascular smooth muscle cells. We have identified neurotransmitter receptors on ICCs within CCDs, suggesting that these cells are responsive to neuronal signals and may thus be the targets of the previously observed innervation.

We identified multiple mAChR subtypes expressed by M-1 cells. We observed high levels of mRNA expression of the m1, m4 and m5 mAChRs and low levels of m3 receptor expression. As m2 receptor mRNA was not amplified from murine renal tissue, we did not examine the expression of this receptor in M-1 cells. The odd numbered mAChR subtypes are Gq receptors, and the even numbered subtypes are Gi receptors. It is well known that Gq and Gi receptors activate the phospholipase C and adenylate cyclase signaling cascades, respectively \[[@r47]\]. However, the function of these receptor subtypes in ICCs remains to be clarified. We observed expression of the m1 subtype in M-1 cells as well as in ICCs and principal cells throughout the murine renal cortex and medulla. This finding suggests that M-1 cells and ICCs may be influenced by the cholinergic system via the m1 receptor. The lack of mAChR-specific antibodies has made the detection of mAChRs in mammalian tissues technically difficult. Because of this, we were able to detect the m1 subtype using immunoblot and immunohistochemical techniques, but were unable to detect the m4 and m5 subtypes, despite multiple attempts with several antibodies. Hence, the full array of mAChRs expressed by ICCs in CCDs remains unclear, and the cholinergic effects on ICCs may be more complex than previously thought.

We also examined AChE expression within the mouse kidney. We found AChE expression in principal cells located near AQP6-positive ICCs. The AChE enzyme catalyzes the degradation of ACh. We observed that the m1 mAChR subtype was expressed in cells of the collecting ducts, including ICCs. Our findings suggest that ACh levels within the kidney may be locally regulated by AChE from principal cells. It has previously been reported that AChE is expressed by multiple renal cell types, including cells in the glomeruli and afferent arterioles, as well as in nephrons and efferent nerve fibers \[[@r4], [@r39]\]. We identified AChE expression in murine glomeruli and nerve fibers, in addition to the collecting ducts. These findings indicate that ACh levels may be locally regulated within various renal tissues. The origin of renal ACh is unknown. The renal nerve plexus contains numerous efferent fibers, however, almost all of these fibers are adrenergic; neither vagal nor sacral nerve fibers innervate renal tissues \[[@r4], [@r12], [@r23], [@r29]\]. In our previous study, we found that some CCD principal cells in rats express choline acetyltransferase (ChAT), an enzyme that catalyzes the synthesis of ACh \[[@r22]\]. ChAT expression was unevenly distributed throughout the CCDs, suggesting localized expression. Another possible source of ACh is migrating cells from extra-renal tissues, such as lymphocytes \[[@r18], [@r48]\]. For example, T lymphocytes have been shown to express ChAT \[[@r17], [@r18], [@r45]\]. There is currently no evidence regarding the localization of ChAT-expressing T lymphocytes in renal tissue, but this may be one mechanism by which ACh is delivered to nephrons.

In conclusion, we showed that M-1 cellular expression of adrenergic and cholinergic receptors mimics that of mouse renal ICCs. To determine whether M-1 cells are useful for the study of the neuronal effects to the ICCs, further studies will be needed.

The authors wish to thank Ms. M. Hatta and Mr. Gion (Hyogo College of Medicine) for their secretarial assistance. This study was supported in part by a Grant-In-Aid for Science Research (C), JSPS, KAKENHI (25460278).
